Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...
The 2023 ACS lung cancer screening guidelines increase eligibility but reduce screening specificity across racial and ethnic subgroups.
In this summary of a panel discussion at the 2026 TTLC Meeting, Dr Estelamari Rodriguez highlights key takeaways from a multidisciplinary conversation on early-stage lung cancer m ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
TTLC 2026 spotlights next-gen lung cancer therapies, co-mutation strategies, and ctDNA monitoring—insights beyond CME for what’s coming next. At the 2026 IASLC Targeted Therapies in Lung Cancer (TTLC) ...
Introduction Incidental pulmonary nodules (IPNs) are commonly encountered on chest radiographs (CXRs) performed for routine clinical indications and may represent early manifestations of significant ...
Diffuse pulmonary meningiotheliomatosis (DPM) and minute pulmonary menigiothelial-like nodules (MPMNs) are rare pulmonary pathologies often detected incidentally. These lesions are often benign.
Background We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden. Methods Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...
For years, scientists have viewed cancer as a localized glitch in which cells refuse to stop dividing. But a new study suggests that, in certain organs, tumors actively communicate with the brain to ...
The disease is the rare cancer met with accusations, not sympathy. By Simar Bajaj Simar Bajaj spoke to over a dozen patients with lung cancer for this story. When Jim Pantelas was diagnosed with lung ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results